Showing 12,241 - 12,260 results of 65,219 for search '(( 50 ms decrease ) OR ( 5 ((((we decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.00s Refine Results
  1. 12241

    DataSheet_1_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-... by Rafaella F. Q. Grenfell (12841457)

    Published 2022
    “…</p>Methods<p>We bring pioneering contributions on the maintenance of the immune response over a year on a real-life basis study in 1,587 individuals (18-90 yrs, median 39 yrs; 1,208 female/379 male) who underwent vaccination with two doses of CoronaVac and BNT162b2 booster after 6-months of primary protocol.…”
  2. 12242
  3. 12243
  4. 12244

    Table_1_Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.DOCX by Irene Soffritti (6053267)

    Published 2021
    “…In conclusion, the data presented here suggest that the HOM profile may be important in defining the individual susceptibility to SARS-CoV-2 infection, facilitating inflammation and virus replication, or rather, inducing a protective IgA response. …”
  5. 12245
  6. 12246
  7. 12247
  8. 12248
  9. 12249
  10. 12250

    Salvianolic acid A alleviates the renal damage in rats with chronic renal failure by Guangming Zhang (467131)

    Published 2019
    “…<div><p>Abstract Purpose: To investigate the protective effects of salvianolic acid A (SAA) on renal damage in rats with chronic renal failure (CRF). …”
  11. 12251
  12. 12252
  13. 12253

    FIGURE 5 from Proteasome Inhibition Reprograms Chromatin Landscape in Breast Cancer by H. Karimi Kinyamu (18387319)

    Published 2024
    “…Each row corresponds to a DOCR, and they are split by increase (<b>GAIN</b>) or decrease (<b>LOST</b>) in accessibility and by genomic category (<b>PROMOTER</b>, <b>GENIC</b>, <b>INTERGENIC</b>). …”
  14. 12254

    Image_5_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

    Published 2023
    “…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”
  15. 12255
  16. 12256

    Data_Sheet_1_A clathrin mediated endocytosis scaffolding protein, Intersectin 1, changes in an isoform, brain region, and sex specific manner in Alzheimer’s disease.PDF by Sierra Jaye (18793159)

    Published 2024
    “…At 3 months, female 5xFAD exhibited an increase of ITSN1-L in CTX but a decrease at 6 and 9 months. …”
  17. 12257

    Table_1_TET Upregulation Leads to 5-Hydroxymethylation Enrichment in Hepatoblastoma.XLS by Maria Prates Rivas (6830132)

    Published 2019
    “…Furthermore, our data suggest that decreased 5hmC content might be associated with poor survival rate, highlighting a pivotal role of epigenetics in hepatoblastoma development and progression.…”
  18. 12258

    Image_3_A Novel Mechanism Regulating Dopamine Receptor Type 2 Signal Transduction in Pituitary Tumoral Cells: The Role of cAMP/PKA-Induced Filamin A Phosphorylation.jpeg by Federica Mangili (10146332)

    Published 2021
    “…In conclusion, our data demonstrated that cAMP pathway and DRD2 agonist regulated FLNA activity by increasing or decreasing, respectively, its phosphorylation. Moreover, we found that P-FLNA prevented DRD2 signaling in PRL- and ACTH-secreting tumoral pituitary cell lines, suggesting that this FLNA modification might represent a new regulatory mechanism shared by different GPCRs. …”
  19. 12259

    Image_1_A Novel Mechanism Regulating Dopamine Receptor Type 2 Signal Transduction in Pituitary Tumoral Cells: The Role of cAMP/PKA-Induced Filamin A Phosphorylation.jpeg by Federica Mangili (10146332)

    Published 2021
    “…In conclusion, our data demonstrated that cAMP pathway and DRD2 agonist regulated FLNA activity by increasing or decreasing, respectively, its phosphorylation. Moreover, we found that P-FLNA prevented DRD2 signaling in PRL- and ACTH-secreting tumoral pituitary cell lines, suggesting that this FLNA modification might represent a new regulatory mechanism shared by different GPCRs. …”
  20. 12260

    Image_2_A Novel Mechanism Regulating Dopamine Receptor Type 2 Signal Transduction in Pituitary Tumoral Cells: The Role of cAMP/PKA-Induced Filamin A Phosphorylation.jpeg by Federica Mangili (10146332)

    Published 2021
    “…In conclusion, our data demonstrated that cAMP pathway and DRD2 agonist regulated FLNA activity by increasing or decreasing, respectively, its phosphorylation. Moreover, we found that P-FLNA prevented DRD2 signaling in PRL- and ACTH-secreting tumoral pituitary cell lines, suggesting that this FLNA modification might represent a new regulatory mechanism shared by different GPCRs. …”